Catch up on the top radiology content of the past week.
|Articles|December 5, 2008
GE introduces new PET/CT
Author(s)Greg Freiherr
Discovery PET/CT 600 debuted at the RSNA meeting, taking a midtier position in GE Healthcare’s family of hybrid devices.
Advertisement
Discovery PET/CT 600 debuted at the RSNA meeting, taking a midtier position in GE Healthcare’s family of hybrid devices. Discovery PET/CT 600 uses an infrared tracking camera and reflective marker to measure a patient’s respiratory pattern and range of motion that can complicate imaging and lead to problems in evaluating patients for radiation therapy. The real-time position-management technology, developed by Varian Medical Systems, was integrated into the GE device through a partnership between the two firms. Synchronizing the scan with respiration requires substantial processing power, according to GE. The company met the challenge through a collaboration with IBM, which provided its BladeCenter server technology for use in the PET/CT.
Advertisement
Related to this article
While a new article raises provocative questions about the capability of photon-counting CT (PCCT) to perhaps replace diagnostic ICA, the real revolution with this modality is going beyond stenosis measurement to a renewed focus on the disease of atherosclerosis.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Catch up on the top radiology content of the past week.
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears First MRI-Derived AI Software for Assessing Breast Cancer Recurrence Risk
2
How AI, Theranostics and More Empowered Patients Have Led to Significant Changes in Radiology
3
See the Real-World Impact of AI in Radiology
4
MRI Study Links Tightness of High-Convexity Sulci to Higher Risk of Cognitive Decline in Older Adults
5